S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic SteatohepatitisXiaolin Liu, Yimin Mao, Minde Zeng et al.|PLoS ONE|2015Cited by 31
Synthesis and clinical application of new drugs approved by FDA in 2022Jingyi Zhang, Zhe‐Sheng Chen|Molecular Biomedicine|2023Cited by 20
Cuproptosis mediates copper-induced testicular spermatogenic cell deathJingyi Zhang, Liang Dong|Asian Journal of Andrology|2024Cited by 13